Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe.

IF 1.6 4区 医学 Q4 INFECTIOUS DISEASES Southern African Journal of Hiv Medicine Pub Date : 2022-01-01 DOI:10.4102/sajhivmed.v23i1.1435
Linda A Mandikiyana Chirimuta, Margaret J Pascoe, Sara Lowe
{"title":"Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe.","authors":"Linda A Mandikiyana Chirimuta,&nbsp;Margaret J Pascoe,&nbsp;Sara Lowe","doi":"10.4102/sajhivmed.v23i1.1435","DOIUrl":null,"url":null,"abstract":"<p><p>We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG.</p><p><strong>What this study adds: </strong>Dolutegravir is the mainstay of HIV treatment programmes and emergence of drug resistance to DTG is of public health relevance.</p>","PeriodicalId":49489,"journal":{"name":"Southern African Journal of Hiv Medicine","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634947/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Southern African Journal of Hiv Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4102/sajhivmed.v23i1.1435","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 2

Abstract

We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG.

What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and emergence of drug resistance to DTG is of public health relevance.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在integrase-naïve中出现的多替格拉韦耐药性,来自津巴布韦的治疗经历患者。
我们报告两例多替替韦(DTG)耐药的高度治疗经验的患者。监测治疗失败和依从性支持是重要的高度治疗经验的患者服用DTG。这项研究补充的内容:多替格拉韦是艾滋病毒治疗规划的支柱,对多替格拉韦的耐药性的出现与公共卫生有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
11.80%
发文量
41
审稿时长
>12 weeks
期刊介绍: The Southern African Journal of HIV Medicine is focused on HIV/AIDS treatment, prevention and related topics relevant to clinical and public health practice. The purpose of the journal is to disseminate original research results and to support high-level learning related to HIV Medicine. It publishes original research articles, editorials, case reports/case series, reviews of state-of-the-art clinical practice, and correspondence.
期刊最新文献
Outcomes and characteristics of patients on protease inhibitors at a tertiary level antiretroviral clinic Promises and potential pitfalls of long-acting injectable pre-exposure prophylaxis. Rural nurses' antiretroviral prescribing practices in children, Limpopo province, South Africa. The prevalence of cervical abnormalities: Comparison of youth with perinatally acquired HIV and older women in Botswana. Effect of HIV on mortality among hospitalised patients in South Africa.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1